M C Benson
Overview
Explore the profile of M C Benson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
895
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Nejat R, Rashid H, Bagiella E, Katz A, Benson M
J Urol
. 2000 Nov;
164(6):1891-4.
PMID: 11061874
Purpose: Patients with prostate cancer are treated with neoadjuvant, adjuvant and intermittent androgen deprivation therapy. Prostate specific antigen (PSA) is altered during androgen deprivation therapy, and as a result the...
12.
Gomella L, Albertsen P, Benson M, Forman J, Soloway M
Semin Urol Oncol
. 2000 Sep;
18(3):182-7.
PMID: 10975489
Increased consumerism, patient empowerment, and autonomy are creating a health care revolution. In recent years, the public has become better informed and more sophisticated. An extraordinary amount of treatment advice...
13.
Choi J, Shendrik I, Peacocke M, Peehl D, Buttyan R, Ikeguchi E, et al.
Urology
. 2000 Jun;
56(1):160-6.
PMID: 10869659
Objectives: Cellular senescence is a unique cellular response pathway thought to be closely associated with the aging process. The senescent phenotype is characterized by the loss of a cell's ability...
14.
Burchardt M, Burchardt T, Shabsigh A, de la Taille A, Benson M, Sawczuk I
Clin Chem
. 2000 May;
46(5):595-605.
PMID: 10794739
Background: Transitional cell carcinoma of the bladder (TCC) is the second most common malignancy of the urinary tract. More than 70% of treated tumors recur, and 30% of recurrent tumors...
15.
de la Taille A, Benson M, Bagiella E, Burchardt M, Shabsigh A, Olsson C, et al.
BJU Int
. 2000 Feb;
85(3):281-6.
PMID: 10671882
Objective: To determine the complication rates and biochemical recurrence after cryoablation of the prostate, using an argon gas-based system, in patients with localized prostate cancer. Patients And Methods: Between October...
16.
de la Taille A, Hayek O, Benson M, Bagiella E, Olsson C, Fatal M, et al.
Urology
. 2000 Feb;
55(1):79-84.
PMID: 10654899
Objectives: Cryotherapy of the prostate represents a potential treatment for localized recurrent prostate cancer after radiation therapy. We report our experience and evaluate the predictive factors for prostate-specific antigen (PSA)...
17.
Brawer M, Benson M, Bostwick D, Djavan B, Lilja H, Semjonow A, et al.
Semin Urol Oncol
. 2000 Jan;
17(4):206-21.
PMID: 10632122
Serum prostate-specific antigen is credited with dramatic advances in the early detection, screening, and management of men with prostatic carcinoma. There has been more than a twofold increase in the...
18.
19.
Hayek O, Noble C, de la Taille A, Bagiella E, Benson M
Curr Opin Urol
. 1999 Dec;
9(5):371-5.
PMID: 10579073
Serum prostate specific antigen, prostate specific antigen density and free:total prostate specific antigen are known to be useful for determining the risk of prostate cancer in patients undergoing prostate cancer...
20.
Lee N, Newhouse J, Olsson C, Benson M, Petrylak D, Schiff P, et al.
Urology
. 1999 Sep;
54(3):490-4.
PMID: 10475360
Objectives: Although a computed tomography (CT) scan of the abdomen and pelvis is often recommended as part of the staging evaluation for newly diagnosed prostate cancer, most scans are negative...